85 FR 51 pgs. 14941-14942 - Notice of Closed Meeting
Type: NOTICEVolume: 85Number: 51Pages: 14941 - 14942
Pages: 14941, 14942FR document: [FR Doc. 2020-05262 Filed 3-13-20; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
[top] The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of
Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-GH16-003, Conducting Public Health Research in Thailand: technical collaboration with the Ministry of Public Health in the Kingdom of Thailand (MOPH); GH19-003, Advancing Infectious Disease Detection and Response in Senegal; GH19-005, Advancing Public Health Research in Bangladesh; GH19-006, Advancing Infectious Disease Detection and Response in Indonesia; GH19-008, Acute Febrile Illness in Uganda; GH19-009, Advancing Infectious Disease Detection and Response in Viet Nam; and GH19-010, Advancing Disease Detection and Response in Nigeria.
Date: April 21, 2020
Time: 9:00 a.m.-2:00 p.m., EDT
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Hylan Shoob, Ph.D., Scientific Review Officer, Center for Global Health, CDC, 1600 Clifton Road NE, Atlanta, Georgia 30329-4027, Telephone (404) 639-4796; HShoob@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-05262 Filed 3-13-20; 8:45 am]
BILLING CODE 4163-18-P